-
challenges and conduct the research needed to accelerate the delivery of solutions to the marketplace. The Reactor and Nuclear Fuel Cycle Analysis Group (RNFCA) Group is seeking candidates to apply
-
phenomena of nuclear reactor fuel cladding and core internal materials. Strong materials characterization skills are required. This position resides in the Fuel Cladding and Core Internals (FCCI) Group in
-
Postdoctoral Researcher in the fields of uranium chemistry and nuclear forensics. The role entails performing and leading cutting-edge research on nuclear fuel cycle-related materials with a focus on solid
-
(NSSD) at Oak Ridge National Laboratory (ORNL). The NND performs research and development to detect, characterize, and monitor nuclear fuel cycle activities and nuclear explosions; develops concepts
-
, high temperature, nuclear environments. This position resides in the Nuclear and Extreme Environment Measurement (NEEM) Group in the Nuclear Energy and Fuel Cycle Division, Fusion and Fission Energy and Science
-
alongside data scientists, software engineers, statisticians, and domain experts, publish and release your work openly, and apply these methods to nuclear nonproliferation and nuclear fuel cycle problems
-
of this role is the study of the chemical and physical properties of molten salt liquids relevant to fission and fusion reactors. The production and recovery of tritium fuel are major challenges for successfully
-
separation, and biomass based chemical and fuel precursors. Selected candidate will be responsible for developing new and exciting ideas, building collaboration within and outside ORNL, and executing
-
on-site, along with their associated supportive technologies (such as solar photovoltaics, solar thermal systems, wind power, renewable fuels, geothermal solutions, battery storage, thermal storage, and
-
and lignocellulosic biomass into domestic fuels and chemicals. Research activities may include creating transformation methods, constructing gene‑expression “genetic parts,” and developing CRISPR‑Cas